{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:25:55Z","timestamp":1765268755431,"version":"3.40.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Fujian Province of China","award":["2018Y0037"],"award-info":[{"award-number":["2018Y0037"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Toxic epidermal necrolysis (TEN) is a rare, severe mucosal response of the skin associated with a high mortality rate. TEN is most commonly caused by drugs, and is characterized by extensive skin epidermal exfoliation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 68-year-old woman presented with a rash that had persisted for four days. The patient who had undergone a mitral valve replacement 1 month prior and was taking atorvastatin at the time of admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient exhibited more than 30% exfoliation surfaces and the severe drug eruption was considered to be TEN. According to human leukocyte antigen (HLA) allele detection and ALDEN score, HLA alleles which found in this case report may be an cause of TEN induced by atorvastatin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>All drugs used prior to admission were discontinued and the patient was given antiallergic drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 3\u200aweeks following Antiallergic treatment, the rash on patient's calf had subsided, the edema was relieved, and the patient was no longer experiencing pain. After 60\u200adays following discharge, the patient's skin has regrown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This is the first report describing the induction of TEN by atorvastatin in a HLA alleles carrier. For HLA alleles carrier, atorvastatin may need to be used with caution to avoid TEN. Future systematic research is also required to confirm this finding and avoid similar serious skin adverse reactions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024392","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T14:00:48Z","timestamp":1611410448000},"page":"e24392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Toxic epidermal necrolysis in a patient on atorvastatin therapy expressing human leukocyte antigen alleles"],"prefix":"10.1097","volume":"100","author":[{"given":"Meina","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Fujian Medical University Union Hospital"},{"name":"College of Pharmacy, Fujian Medical University, Fuzhou, Fujian"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaojun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fujian Medical University Union Hospital"},{"name":"College of Pharmacy, Fujian Medical University, Fuzhou, Fujian"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fujian Medical University Union Hospital"},{"name":"College of Pharmacy, Fujian Medical University, Fuzhou, Fujian"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fujian Medical University Union Hospital"},{"name":"Department of Pharmacy, Huaihe Hospital of Henan University, Kaifeng, Henan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siheng","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fujian Medical University Union Hospital"},{"name":"College of Pharmacy, Fujian Medical University, Fuzhou, Fujian"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fujian Medical University Union Hospital"},{"name":"College of Pharmacy, Fujian Medical University, Fuzhou, Fujian"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jid.2017.01.003","article-title":"Stevens-Johnson Syndrome and toxic epidermal necrolysis: associations, outcomes, and pathobiology-thirty years of progress but still much to be done","volume":"137","author":"Stern","year":"2017","journal-title":"J Investig Dermatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R3-20250504","first-page":"4320195","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China","volume":"2018","author":"Yang","year":"2018","journal-title":"J Immunol Res"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R5-20250504","first-page":"3186328","article-title":"\u201cHLA association with drug-induced adverse reactions\u201d","author":"Fan","year":"2017","journal-title":"J Immunol Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update [J]","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neurol.2017.11.006","article-title":"The HLA-B15:02 polymorphism and Tegretol((R))-induced serious cutaneous reactions in epilepsy: an updated systematic review and meta-analysis","volume":"174","author":"Chouchi","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.bjps.2016.01.034","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"69","author":"Creamer","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R9-20250504","first-page":"151","article-title":"Clinical analysis of atorvastatin inducing skin adverse reactions in carbamazepine","volume":"11","author":"Wei","year":"2014","journal-title":"China Modern Pharmaceutical Applications"},{"key":"R10-20250504","first-page":"95","article-title":"A case of acute intrahepatic cholestasis and exfoliative dermatitis caused by atorvastatin calcium tablets","volume":"8","author":"Xiao","year":"2014","journal-title":"China Pharmaceut"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jama.279.20.1613-a","article-title":"Toxic epidermal necrolysis from atorvastatin","volume":"279","author":"Pfeiffer","year":"1998","journal-title":"JAMA"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5144\/0256-4947.2012.309","article-title":"A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis","volume":"32","author":"Noordally","year":"2012","journal-title":"Ann Saudi Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0906-6705.2004.00208.x","article-title":"Statins: novel additions to the dermatologic arsenal?","volume":"13","author":"Namazi","year":"2004","journal-title":"Exp Dermatol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S2221-6189(14)60072-X","article-title":"Simvastatin-induced Toxic Epidermal Necrolysis","volume":"4","author":"Petrou","year":"2014","journal-title":"Journal of Acute Diseases"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-0039.2009.01237.x","article-title":"Distribution of HLA-A, -B, -Cw, and -DRB1 alleles and haplotypes in an isolated Han population in Southwest China","volume":"73","author":"Yao","year":"2009","journal-title":"Tissue Antigens"},{"key":"R17-20250504","first-page":"237","article-title":"Research Progress of HLA-B15:02 Alleles and Antiepileptic Drugs in Serious Sexual Skin Adverse Reactions","volume":"4","author":"Cheng","year":"2011","journal-title":"Chinese Journal of Pharmacovigilance"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphar.2017.00879","article-title":"Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population","volume":"8","author":"Koomdee","year":"2017","journal-title":"Front Pharmacol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","article-title":"HLA-B15:02\u2013bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome[J]","volume":"120","author":"Yang","year":"2007","journal-title":"J Allergy Clin Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:02:36Z","timestamp":1746342156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024392"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024392","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"2020-10-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}